Search
Patexia Research
Case number 2:21-cv-10398

CELGENE CORPORATION v. HIKMA PHARMACEUTICALS USA, INC. > Summary

Court Case Number 2:21-cv-10398

Filing Date Apr 28, 2021

Termination Date Jan 13, 2022

Court New Jersey District Court

Status Judgment - Judgment on Consent

JudgesSusan D. Wigenton, Leda D. Wettre

Plaintiff

Celgene

Defendant

Hikma Pharmaceuticals PLC

Cause

35:271 Patent Infringement

Related Patents

Doc No Title Issue date
09101621 Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation Aug 11, 2015
09101622 Methods for treating newly diagnosed multiple myeloma 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone Aug 11, 2015
09056120 Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine Jun 16, 2015
08648095 Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor Feb 11, 2014
08530498 Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione Sep 10, 2013
08404717 Methods of treating myelodysplastic syndromes using lenalidomide Mar 26, 2013
07968569 Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione Jun 28, 2011
07855217 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione Dec 21, 2010
07465800 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione Dec 16, 2008
07189740 Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes Mar 13, 2007
Menu